Subventions financées

Using the mirror image of body’s main sugar glucose (so-called L-glucose), we plan to hijack the sugar addiction of glioblastoma (GBM) as a therapeutic target.

Amyotrophic Lateral Sclerosis (ALS) is a fatal disease that progressively destroys motor neurons, leading to paralysis and death, with no current cure.

The Role of Brain Endocannabinoid Metabolism in Social Anxiety Disorder and Social Stress

Jenna Hanrahan, a Doctoral Student at Memorial University of Newfoundland, aims to characterize the brain of a humanized mouse model of Huntington’s disease.

Amyotrophic Lateral Sclerosis (ALS) is a progressive disease that destroys the motor neurons needed for movement, speech, and breathing, but new research shows that other spinal cord cells called interneurons may be affected even earlier.

To accelerate the process of developing new drugs and treatments for CNS disorders, we propose to establish the Center for Accelerating Neuroscience Drug and Imaging Development (CANDID), a central platform that will improve the efficiency of the drug discovery process for CNS diseases in Canada by developing specific tools and state-of-the-art biotechnologies to increase our capability to identify, test, and validate new CNS drug candidates.

Amyotrophic lateral sclerosis (ALS) is a terminal disease of nerves and muscles. From the time of symptom onset, people with ALS live about 3-5 years.

As people live longer, our society undergoes rapid demographic change.

Autism spectrum disorder (ASD) is a complex condition affecting communication, social interactions, and behavior in approximately 1–2% of people worldwide.

In Canada, over 1 million people have been diagnosed with bipolar disorder (BD) in their lifetime.